Literature DB >> 5062439

Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.

H Závadová, E Adam, V Vonka, E Domorázková, M Kratochvílová, V Burian, F M Davenport.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5062439

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  3 in total

1.  Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years.

Authors:  H Závadová; V Vonka; E Adam; E Domorázková; F M Davenport
Journal:  Arch Gesamte Virusforsch       Date:  1972

2.  Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus.

Authors:  E Adam; V Burian; E Kubátová; M Kratochvílovă; B Buriánov'A; M Kyselová; M Demelová; E Hejdová
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1970

3.  Vaccination of infants against influenza with polyvalent influenza hemagglutinin.

Authors:  A V Hennessy; F M Davenport
Journal:  JAMA       Date:  1967-06-05       Impact factor: 56.272

  3 in total
  2 in total

1.  Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine.

Authors:  R Jennings; T L Smith; A R Mellersh; A Clark; R C Spencer; C W Potter
Journal:  J Hyg (Lond)       Date:  1985-02

Review 2.  Fractional dose of intradermal compared to intramuscular and subcutaneous vaccination - A systematic review and meta-analysis.

Authors:  Jenny L Schnyder; Cornelis A De Pijper; Hannah M Garcia Garrido; Joost G Daams; Abraham Goorhuis; Cornelis Stijnis; Frieder Schaumburg; Martin P Grobusch
Journal:  Travel Med Infect Dis       Date:  2020-09-06       Impact factor: 6.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.